iTeos Therapeutics

Foundation date

01/08/2011

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients . We leverage our deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve the clinical benefit of oncology therapies.

Upcoming events

Latest news

  • Triple discovery unveils insights into type 2 diabetes

    Thursday September 28th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023

  • Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen

    Wednesday September 27th 2023